The First School of Clinical Medicine, 12426Lanzhou University, Lanzhou, Gansu, China.
The Second School of Clinical Medicine, 12426Lanzhou University, Lanzhou, Gansu, China.
Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221117386. doi: 10.1177/15330338221117386.
Osteosarcoma is one of the most common primary malignant bone tumors, mainly occurring in children and adolescents, and is characterized by high morbidity and poor prognosis. MicroRNAs, a class of noncoding RNAs consisting of 19 to 25 nucleotides, are involved in cell proliferation, invasion, metastasis, and apoptosis to regulate the development and progression of osteosarcoma. Studies have found that microRNAs are closely related to the diagnosis, treatment, and prognosis of osteosarcoma patients and have an important role in improving drug resistance in osteosarcoma. This paper reviews the role of microRNAs in the pathogenesis of osteosarcoma and their clinical value, aiming to provide a new research direction for diagnosing and treating osteosarcoma and achieving a better prognosis.
骨肉瘤是最常见的原发性恶性骨肿瘤之一,主要发生在儿童和青少年,其特点是发病率高,预后差。 microRNAs 是一类由 19 到 25 个核苷酸组成的非编码 RNA,参与细胞增殖、侵袭、转移和凋亡,调节骨肉瘤的发生和发展。研究发现,microRNAs 与骨肉瘤患者的诊断、治疗和预后密切相关,在提高骨肉瘤耐药性方面具有重要作用。本文综述了 microRNAs 在骨肉瘤发病机制中的作用及其临床价值,旨在为骨肉瘤的诊断和治疗提供新的研究方向,实现更好的预后。